ONVO Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 3.72%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Organovo Share Price & Price History
Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 04/23/2025 05:00 PM ET
Organovo Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/15/2023 | David Gobel | Director | Sell | 1,633 | $19.44 | $31,745.52 | 1,633 |  |
Organovo Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/7/2025 | Prescott Group Capital Management L.L.C. | 280,511 | $0.13M | 0.0% | -32.2% | 1.825% |  |
| 8/15/2024 | Armistice Capital LLC | 929,000 | $0.71M | 0.0% | N/A | 6.465% | |
| 8/9/2024 | Renaissance Technologies LLC | 63,387 | $48K | 0.0% | -35.2% | 0.441% | |
| 2/13/2023 | Nikko Asset Management Americas Inc. | 454,752 | $0.64M | 0.0% | -1.4% | 5.221% | |
| 1/30/2023 | Sumitomo Mitsui Trust Holdings Inc. | 454,752 | $0.64M | 0.0% | -1.4% | 5.221% | |
| 1/24/2023 | ARK Investment Management LLC | 214,302 | $0.30M | 0.0% | -22.0% | 2.460% | |
| 11/7/2022 | Virtu Financial LLC | 14,703 | $30K | 0.0% | N/A | 0.169% | |
| 10/17/2022 | ARK Investment Management LLC | 274,867 | $0.56M | 0.0% | -5.7% | 3.155% | |
| 8/4/2022 | Nikko Asset Management Americas Inc. | 464,426 | $0.51M | 0.0% | -3.0% | 5.332% | |
| 7/26/2022 | Sumitomo Mitsui Trust Holdings Inc. | 464,426 | $0.82M | 0.0% | -3.0% | 5.332% | |
| 7/11/2022 | ARK Investment Management LLC | 291,633 | $0.70M | 0.0% | -4.7% | 3.348% | |
| 4/19/2022 | ARK Investment Management LLC | 306,108 | $1.15M | 0.0% | -7.3% | 3.516% | |
| 2/10/2022 | Prescott Group Capital Management L.L.C. | 55,170 | $0.20M | 0.0% | N/A | 0.634% | |
| 1/28/2022 | ARK Investment Management LLC | 330,157 | $1.20M | 0.0% | -13.5% | 3.793% | |
| 12/8/2021 | Moors & Cabot Inc. | 25,000 | $27K | 0.0% | N/A | 0.287% | |
| 11/12/2021 | Renaissance Technologies LLC | 120,887 | $0.82M | 0.0% | -21.5% | 1.389% | |
| 11/5/2021 | Moors & Cabot Inc. | 25,000 | $27K | 0.0% | N/A | 0.287% | |
| 11/5/2021 | Advisor Group Holdings Inc. | 4,902 | $34K | 0.0% | -26.7% | 0.056% | |
| 10/29/2021 | Commonwealth Equity Services LLC | 12,292 | $83K | 0.0% | -59.0% | 0.141% | |
| 8/16/2021 | State Street Corp | 27,831 | $0.26M | 0.0% | N/A | 0.320% | |
Data available starting January 2016
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.
Read More on Organovo
Today's Range
Now: N/A
52 Week Range
Now: N/A
Volume
243,634 shs
Average Volume
617,505 shs
Market Capitalization
$3.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.13
